The Value of Morphometry to Predict Chemotherapy Response in Advanced Ovarian Cancer
- 31 December 1989
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 185 (5) , 676-679
- https://doi.org/10.1016/s0344-0338(89)80215-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patientsBritish Journal of Cancer, 1988
- Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features aloneThe Journal of Pathology, 1988
- Prognostic Factors in Borderline and Invasive Ovarian Tumours of the Common Epithelial TypePathology - Research and Practice, 1987
- An improved human tumor stem cell assay in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1987
- Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours.Journal of Clinical Pathology, 1986
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- Advanced ovarian cancer correlation of histologic grade with response to therapy and survivalCancer, 1980
- Selection of Variables in Discriminant Analysis by F-Statistic and Error RateTechnometrics, 1977